These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7193208)
1. Binding of saframycin A, a heterocyclic quinone anti-tumor antibiotic to DNA as revealed by the use of the antibiotic labeled with [14C]tyrosine or [14C]cyanide. Ishiguro K; Takahashi K; Yazawa K; Sakiyama S; Arai T J Biol Chem; 1981 Mar; 256(5):2162-7. PubMed ID: 7193208 [TBL] [Abstract][Full Text] [Related]
2. Structure and conformation of saframycin R determined by high field 1H and 13C NMR and its interactions with DNA in solution. Lown JW; Hanstock CC; Joshua AV; Arai T; Takahashi K J Antibiot (Tokyo); 1983 Sep; 36(9):1184-94. PubMed ID: 6630077 [TBL] [Abstract][Full Text] [Related]
3. Biosynthetic studies on saframycin A, a quinone antitumor antibiotic produced by Streptomyces lavendulae. Mikami Y; Takahashi K; Yazawa K; Arai T; Namikoshi M; Iwasaki S; Okuda S J Biol Chem; 1985 Jan; 260(1):344-8. PubMed ID: 3880741 [TBL] [Abstract][Full Text] [Related]
4. Directed biosynthesis of new saframycin derivatives with resting cells of Streptomyces lavendulae. Arai T; Yazawa K; Takahashi K; Maeda A; Mikami Y Antimicrob Agents Chemother; 1985 Jul; 28(1):5-11. PubMed ID: 3839995 [TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of binding and single-strand scission of deoxyribonucleic acid by the antitumor antibiotics saframycins A and C. Lown JW; Joshua AV; Lee JS Biochemistry; 1982 Feb; 21(3):419-28. PubMed ID: 7066293 [TBL] [Abstract][Full Text] [Related]
6. [Discovery and development of unknown potentialities of microorganisms with special reference to saframycin group antitumor antibiotics]. Arai T Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2617-24. PubMed ID: 6508318 [TBL] [Abstract][Full Text] [Related]
7. Mode of action of saframycin antitumor antibiotics: sequence selectivities in the covalent binding of saframycins A and S to deoxyribonucleic acid. Rao KE; Lown JW Chem Res Toxicol; 1990; 3(3):262-7. PubMed ID: 2131839 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of saframycins. X. Transformation of (-)-saframycin A to (-)-saframycin Mx type compound with the structure proposed for saframycin E. Saito N; Harada S; Nishida M; Inouye I; Kubo A Chem Pharm Bull (Tokyo); 1995 May; 43(5):777-82. PubMed ID: 7553964 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of saframycins. Kishi K; Yazawa K; Takahashi K; Mikami Y; Arai T J Antibiot (Tokyo); 1984 Aug; 37(8):847-52. PubMed ID: 6480503 [TBL] [Abstract][Full Text] [Related]
10. Saframycin S, a new saframycin group antibiotic. Mikami Y; Yokoyama K; Tabeta H; Nakagaki K; Arai T J Pharmacobiodyn; 1981 Apr; 4(4):282-6. PubMed ID: 7264873 [TBL] [Abstract][Full Text] [Related]
11. Isolation and structural elucidation of new saframycins Y3, Yd-1, Yd-2, Ad-1, Y2b and Y2b-d. Yazawa K; Takahashi K; Mikami Y; Arai T; Saito N; Kubo A J Antibiot (Tokyo); 1986 Dec; 39(12):1639-50. PubMed ID: 3818437 [TBL] [Abstract][Full Text] [Related]
12. Structural studies on minor components of saframycin group antibiotics saframycins F, G and H. Mikami Y; Takahashi K; Yazawa K; Hour-Young C; Arai T; Saito N; Kubo A J Antibiot (Tokyo); 1988 Jun; 41(6):734-40. PubMed ID: 3403367 [TBL] [Abstract][Full Text] [Related]
13. The in vitro interaction of naphthyridinomycin with deoxyribonucleic acids. Zmijewski MJ; Miller-Hatch K; Mikolajczak M Chem Biol Interact; 1985 Jan; 52(3):361-75. PubMed ID: 3971473 [TBL] [Abstract][Full Text] [Related]
14. [High-yield synthesis of 14C labeled alicyclic amino acids with high specific radioactivity using potassium (14C) cyanide]. Shiba K; Mori H; Hisada K Radioisotopes; 1986 Jul; 35(7):361-6. PubMed ID: 3786840 [TBL] [Abstract][Full Text] [Related]
15. Some chemotherapeutic properties of two new antitumor antibiotics, saframycins A and C. Arai T; Takahashi K; Ishiguro K; Mikami Y Gan; 1980 Dec; 71(6):790-6. PubMed ID: 7274625 [TBL] [Abstract][Full Text] [Related]
16. Increased production of saframycin A and isolation of saframycin S. Arai T; Takahashi K; Ishiguro K; Yazawa K J Antibiot (Tokyo); 1980 Sep; 33(9):951-60. PubMed ID: 7440416 [TBL] [Abstract][Full Text] [Related]
17. Pyrrolo(1,4)benzodiazepine antitumor antibiotics. In vitro interaction of anthramycin, sibiromycin and tomaymycin with DNA using specifically radiolabelled molecules. Hurley LH; Gairola C; Zmijewski M Biochim Biophys Acta; 1977 Apr; 475(3):521-35. PubMed ID: 15599 [TBL] [Abstract][Full Text] [Related]
18. Computer simulation of the binding of saframycin A to d (GATGCATC)2. Hill GC; Remers WA J Med Chem; 1991 Jul; 34(7):1990-8. PubMed ID: 2066972 [TBL] [Abstract][Full Text] [Related]
19. Identification of the essential tyrosine residue in the beta subunit of bovine heart mitochondrial F1-ATPase that is modified by 7-chloro-4-nitro[14C]benzofurazan. Andrews WW; Hill FC; Allison WS J Biol Chem; 1984 Jul; 259(13):8219-25. PubMed ID: 6234310 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of new semisynthetic saframycin derivatives. Kaneda S; Hour-Young C; Yazawa K; Takahashi K; Mikami Y; Arai T Jpn J Cancer Res; 1986 Oct; 77(10):1043-9. PubMed ID: 3096920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]